Why the study?
Wearable, non-invasive, user-friendly medical devices providing reliable real-life measures of SpO2 and HR during daily activities for monitoring respiratory failure in chronic CVD and CRD are lacking.
Does the BrOxy M wrist-worn device accurately measure SpO2 and HR compared to a reference medical pulse oximeter in healthy volunteers?
Does the BrOxy M wrist-worn device accurately measure SpO2 and HR compared to a reference medical pulse oximeter in healthy volunteers?
The BrOxy M wrist-worn device provides accurate and reliable continuous measurements of SpO2 and HR that are comparable to a reference medical pulse oximeter.
Answers are grounded in this paper and cite their sources.
BrOxy M shows acceptable accuracy for SpO2/HR in controlled settings; leaves open validation in real-world CVD/CRD patients before routine use.
Early diagnosis and continuous monitoring of respiratory failure (RF) in the course of the most prevalent chronic cardio-vascular (CVD) and respiratory diseases (CRD) are a clinical, unresolved problem because wearable, non-invasive, and user-friendly medical devices, which could grant reliable measures of the oxygen saturation (SpO2) and heart rate (HR) in real-life during daily activities are still lacking. In this study, we investigated the agreement between a new medical wrist-worn device (BrOxy M) and a reference, medical pulseoximeter (Nellcor PM 1000N). Twelve healthy volunteers (aged 20−51 years, 84% males, 33% with black skin, obtaining, during the controlled hypoxia test, the simultaneous registration of 219 data pairs, homogeneously deployed in the levels of Sat.O2 97%, 92%, 87%, 82% [ISO 80601-2-61:2017 standard (paragraph EE.3)]) were included. The paired T test 0 and the Bland-Altman plot were performed to assess bias and accuracy. SpO2 and HR readings by the two devices resulted significantly correlated (r = 0.91 and 0.96, p < 0.001, respectively). Analyses excluded the presence of proportional bias. For SpO2, the mean bias was −0.18% and the accuracy (ARMS) was 2.7%. For HR the mean bias was 0.25 bpm and the ARMS3.7 bpm. The sensitivity to detect SpO2 ≤ 94% was 94.4%. The agreement between BrOxy M and the reference pulse oximeter was “substantial” (for SpO2 cut-off 94% and 90%, k = 0.79 and k = 0.80, respectively). We conclude that BrOxy M demonstrated accuracy, reliability and consistency in measuring SpO2 and HR, being fully comparable with a reference medical pulseoxymeter, with no adverse effects. As a wearable device, Broxy M can measure continually SpO2 and HR in everyday life, helping in detecting and following up CVD and CRD subjects.
No takes yet. Share an insight, caveat, or question.
Marinari et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: